228 related articles for article (PubMed ID: 15858010)
1. Epitope-mapping studies define two major neutralization sites on the vaccinia virus extracellular enveloped virus glycoprotein B5R.
Aldaz-Carroll L; Whitbeck JC; Ponce de Leon M; Lou H; Hirao L; Isaacs SN; Moss B; Eisenberg RJ; Cohen GH
J Virol; 2005 May; 79(10):6260-71. PubMed ID: 15858010
[TBL] [Abstract][Full Text] [Related]
2. Neutralizing and protective antibodies directed against vaccinia virus envelope antigens.
Galmiche MC; Goenaga J; Wittek R; Rindisbacher L
Virology; 1999 Feb; 254(1):71-80. PubMed ID: 9927575
[TBL] [Abstract][Full Text] [Related]
3. Antibodies against the extracellular enveloped virus B5R protein are mainly responsible for the EEV neutralizing capacity of vaccinia immune globulin.
Bell E; Shamim M; Whitbeck JC; Sfyroera G; Lambris JD; Isaacs SN
Virology; 2004 Aug; 325(2):425-31. PubMed ID: 15246280
[TBL] [Abstract][Full Text] [Related]
4. Antibody neutralization of the extracellular enveloped form of vaccinia virus.
Law M; Smith GL
Virology; 2001 Feb; 280(1):132-42. PubMed ID: 11162827
[TBL] [Abstract][Full Text] [Related]
5. Functional analysis of vaccinia virus B5R protein: essential role in virus envelopment is independent of a large portion of the extracellular domain.
Herrera E; Lorenzo MM; Blasco R; Isaacs SN
J Virol; 1998 Jan; 72(1):294-302. PubMed ID: 9420227
[TBL] [Abstract][Full Text] [Related]
6. Functional analysis of vaccinia virus B5R protein: role of the cytoplasmic tail.
Lorenzo MM; Herrera E; Blasco R; Isaacs SN
Virology; 1998 Dec; 252(2):450-7. PubMed ID: 9878625
[TBL] [Abstract][Full Text] [Related]
7. Vaccination of BALB/c mice with Escherichia coli-expressed vaccinia virus proteins A27L, B5R, and D8L protects mice from lethal vaccinia virus challenge.
Berhanu A; Wilson RL; Kirkwood-Watts DL; King DS; Warren TK; Lund SA; Brown LL; Krupkin AK; Vandermay E; Weimers W; Honeychurch KM; Grosenbach DW; Jones KF; Hruby DE
J Virol; 2008 Apr; 82(7):3517-29. PubMed ID: 18199639
[TBL] [Abstract][Full Text] [Related]
8. Parainfluenza virus 5-based vaccine vectors expressing vaccinia virus (VACV) antigens provide long-term protection in mice from lethal intranasal VACV challenge.
Clark KM; Johnson JB; Kock ND; Mizel SB; Parks GD
Virology; 2011 Oct; 419(2):97-106. PubMed ID: 21885079
[TBL] [Abstract][Full Text] [Related]
9. The extracellular domain of vaccinia virus protein B5R affects plaque phenotype, extracellular enveloped virus release, and intracellular actin tail formation.
Mathew E; Sanderson CM; Hollinshead M; Smith GL
J Virol; 1998 Mar; 72(3):2429-38. PubMed ID: 9499104
[TBL] [Abstract][Full Text] [Related]
10. Antibodies against vaccinia virus do not neutralize extracellular enveloped virus but prevent virus release from infected cells and comet formation.
Vanderplasschen A; Hollinshead M; Smith GL
J Gen Virol; 1997 Aug; 78 ( Pt 8)():2041-8. PubMed ID: 9267005
[TBL] [Abstract][Full Text] [Related]
11. The vaccinia virus 42-kDa envelope protein is required for the envelopment and egress of extracellular virus and for virus virulence.
Engelstad M; Smith GL
Virology; 1993 Jun; 194(2):627-37. PubMed ID: 8503178
[TBL] [Abstract][Full Text] [Related]
12. A constitutively expressed vaccinia gene encodes a 42-kDa glycoprotein related to complement control factors that forms part of the extracellular virus envelope.
Engelstad M; Howard ST; Smith GL
Virology; 1992 Jun; 188(2):801-10. PubMed ID: 1585649
[TBL] [Abstract][Full Text] [Related]
13. Epitope mapping by random peptide phage display reveals essential residues for vaccinia extracellular enveloped virion spread.
He Y; Wang Y; Struble EB; Zhang P; Chowdhury S; Reed JL; Kennedy M; Scott DE; Fisher RW
Virol J; 2012 Sep; 9():217. PubMed ID: 23006741
[TBL] [Abstract][Full Text] [Related]
14. Epitope mapping of herpes simplex virus type 2 gH/gL defines distinct antigenic sites, including some associated with biological function.
Cairns TM; Shaner MS; Zuo Y; Ponce-de-Leon M; Baribaud I; Eisenberg RJ; Cohen GH; Whitbeck JC
J Virol; 2006 Mar; 80(6):2596-608. PubMed ID: 16501070
[TBL] [Abstract][Full Text] [Related]
15. Characterization of a vaccinia virus-encoded 42-kilodalton class I membrane glycoprotein component of the extracellular virus envelope.
Isaacs SN; Wolffe EJ; Payne LG; Moss B
J Virol; 1992 Dec; 66(12):7217-24. PubMed ID: 1433514
[TBL] [Abstract][Full Text] [Related]
16. Monoclonal antibody mapping of the envelope glycoprotein of the dengue 2 virus, Jamaica.
Roehrig JT; Bolin RA; Kelly RG
Virology; 1998 Jul; 246(2):317-28. PubMed ID: 9657950
[TBL] [Abstract][Full Text] [Related]
17. Deletion of the vaccinia virus B5R gene encoding a 42-kilodalton membrane glycoprotein inhibits extracellular virus envelope formation and dissemination.
Wolffe EJ; Isaacs SN; Moss B
J Virol; 1993 Aug; 67(8):4732-41. PubMed ID: 8331727
[TBL] [Abstract][Full Text] [Related]
18. Extracellular enveloped vaccinia virus escapes neutralization.
Ichihashi Y
Virology; 1996 Mar; 217(2):478-85. PubMed ID: 8610439
[TBL] [Abstract][Full Text] [Related]
19. Production and characterization of monoclonal antibodies to simian immunodeficiency virus envelope glycoproteins.
Babas T; Le Grand R; Dormont D; Bahraoui E
AIDS Res Hum Retroviruses; 1997 Sep; 13(13):1109-19. PubMed ID: 9282816
[TBL] [Abstract][Full Text] [Related]
20. Characterization of an antigenic site that contains a dominant, type-specific neutralization determinant on the envelope protein domain III (ED3) of dengue 2 virus.
Gromowski GD; Barrett AD
Virology; 2007 Sep; 366(2):349-60. PubMed ID: 17719070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
